Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest vs GnRH Agonist Pre-treatment for Endometriosis IVF
NCT03142035Unknown
- Sponsor
- American University of Beirut Medical Center
- Start
- Oct 2017
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dienogest in endometriosis (3 arms), sponsored by American University of Beirut Medical Center. Primary endpoint: Ongoing pregnancy rate. Status: unknown.
02
Drugs
dienogest
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT03142035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03142035.